Loredana Mariana Curecheriu

Dr. Loredana Mariana Curecheriu

Neurosurgery, Grigore T. Popa University of Medicine and Pharmacy, Iaşi, Romania
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Loredana Mariana CurecheriuLoredana Mariana Curecheriu
Loredana Mariana Curecheriu
BIBogdan Florin Iliescu
Bogdan Florin Iliescu
RPRobert Mihai Pintilie
Robert Mihai Pintilie
MTMihaela Dana Turliuc
Mihaela Dana Turliuc
Due to a continuous increase in life expectancy and the progress made in specialized healthcare, the incidence of Alzheimer’s disease (AD) has dramatically increased to the point that it has become one of the main challenges of contemporary medicine. Despite a huge scientific and clinical effort, current treatments manage just a temporary alleviation of symptomatology but offer no cure. Modern trials involving cell transplantation in experimental animals require the involvement of neurosurgeons in the treatment protocol. CSF shunting, intraventricular infusions, or DBS for symptoms relief have been an integral part of the therapeutic arsenal from the very beginning. The development of stereotactic surgery has facilitated the experimental potential of cell transplantation in the hippocampus for Alzheimer’s disease. We conducted a narrative review of the literature in the top three medical databases (PubMed, Science Direct, and Google Scholar) using the keywords “Alzheimer’s disease”, “hippocampus”, and “transplant”. After eliminating duplicates, 241 papers were selected and screened by title and Two reviewers independently analyzed the 88 papers and chose 32 experiments that involved stereotactic hippocampal transplantation of cells in experimental animals with AD. The stereotactic transplantation of cells such as mesenchymal stem cells (MSCs), neuronal stem cells (NSCs), induced pluripotent cells (iPSCs), astrocytes, and derivates from stem cells was analyzed. The experiments used either a chemically induced or transgenic AD model and observed the impact of the stereotactic transplantation with behavioral testing, MRS spectroscopy, and biochemical analysis. The stereotaxic method delivers minimal invasive treatment option by cell transplantation at the hippocampus. The results showed that amyloid deposits were lower after transplantation, showing a positive impact. Other impactful results involve proliferation of neurogenesis, downregulation of anti-inflammatory response, and increased neuronal plasticity. The increased precision with which the stereotaxic method manages to target deep structures of the brain and the results of the reviewed papers could represent an argument for future human trials. More studies are needed to confirm the viability of the transplanted cells and the long-term effects.

15 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BIBogdan Florin Iliescu
Bogdan Florin Iliescu
DRDaniel Ilie Rotariu
Daniel Ilie Rotariu
Loredana Mariana CurecheriuLoredana Mariana Curecheriu
Loredana Mariana Curecheriu
BCBogdan Costachescu
Bogdan Costachescu
Spinal metastasis remains a significant clinical issue, frequently resulting in substantial pain and disability among cancer patients. Conventional management strategies have historically included chemotherapy, radiotherapy, and open surgical intervention. However, advancements in minimally invasive spinal surgery (MISS) have notably shifted the therapeutic landscape. This review examines recent evidence surrounding MISS, directly comparing it to traditional open procedures. Current literature demonstrates that MISS typically results in reduced intraoperative blood loss, shorter hospitalization durations, decreased infection rates, and functional outcomes that are at least equivalent—if not superior—to those of open surgery. Additionally, the emergence of hybrid therapeutic approaches—specifically, the utilization of separation surgery followed by stereotactic radiosurgery—has shown promise in achieving local tumor control, particularly in select malignancies. This narrative review also evaluates contemporary clinical decision-making frameworks such as NOMS, LMNOP, and NESMS. Further, it advocates for the integration of advanced prognostic tools and tumor genomics to enable more personalized treatment strategies for individuals with spinal metastasis.

24 April 2026 in Neurology International
Verified
Journal Article
Open access
PDF file
Loredana Mariana CurecheriuLoredana Mariana Curecheriu
Loredana Mariana Curecheriu
BIBogdan Florin Iliescu
Bogdan Florin Iliescu
Gabriela-Dumitrita StanciuGabriela-Dumitrita Stanciu
Gabriela-Dumitrita Stanciu
IMIvona Mazarianu
Ivona Mazarianu
Andrei SzilagyiAndrei Szilagyi
Andrei Szilagyi
MTMihaela Dana Turliuc
Mihaela Dana Turliuc
Background: Standardized and ethically compliant animal models remain essential for improving translational research in Alzheimer’s disease. Although Aβ1–42-induced rodent models are widely used, methodological variability continues to limit reproducibility. Methods: We explored the feasibility of a stereotactic intrahippocampal Aβ1–42 rat model established by bilaterally injecting pre-aggregated peptide into the hippocampus of adult Sprague Dawley rats. Model feasibility and targeting accuracy were assessed intraoperatively. Cognitive performance was evaluated using the Y-maze for spatial recognition memory and the novel object recognition (NOR) test. Histological examination was performed using hematoxylin–eosin (H&E) and Congo red staining to assess cytoarchitecture and to provide supportive evidence of amyloid-like deposits. Results: The surgical procedure was well-tolerated, and the injected animals showed reduced performance in behavioural testing, including reduced spatial recognition memory in the Y-maze and decreased discrimination indices in the NOR test. The animals also showed histological changes, including Congo red-positive birefringent structures consistent with amyloid-like congophilic material. Conclusions: This study presents a feasible experimental framework for intrahippocampal Aβ1–42 administration, showing behavioural and histological changes under the present experimental conditions. However, further validation, including sham-operated controls and molecular characterization, will be required before these findings can be interpreted as specific to Aβ-driven pathology.

15 September 2022 in Romanian Neurosurgery
Verified
Journal Article
Open access
PDF file
TRTracicaru R.V.
Tracicaru R.V.
CACucu A.I.
Cucu A.I.
Loredana Mariana CurecheriuLoredana Mariana Curecheriu
Loredana Mariana Curecheriu
TMTurliuc Dana Mihaela
Turliuc Dana Mihaela
Introduction: Brain abscesses caused by Nocardia farcinica pathogen are rare and usually present as large abscesses with a thick and irregular wall. We present a case of a patient with signs and symptoms of central nervous system infection and had a fulminant evolution with malign cerebral oedema and death. Case report: The 35-year-old patient presented with mild symptoms that appeared 2 weeks prior and became more aggressive in the last 48 hours. After the initial examination and blood tests, the patient was suspected of a systemic infection because of the high white cell count and high level of inflammatory markers. Antibiotic therapy was started with Ciprofloxacin and Amoxicillin/ Clavulanic Acid. The brain MRI showed a multinodular lesion in the right hemisphere, with contrast enhancement and central high diffusion restriction on T1, T2 and FLAIR. During the antibiotic treatment, the patient suddenly became comatose. Urgent brain CT scan showed malign cerebral oedema with brain shift. Discussion: There are 58 documented cases of Nocardia farcinica in the literature, as shown in a recent systematic review. Most of the cases are with immunocompromised patients, either through disease or secondary to treatment after organ transplant. In our case, we suspected immunodeficiencies based on the anamnestic data offered by the patient's family. Mortality rates are between 19% and 36,7% in all reported cases, but in our presented case the patient had a rapid aggressive evolution with malign brain oedema that resulted in death. Conclusions. The management of these cases requires urgent diagnostics and treatment. For our team, the first reported case of Nocardia farcinica and the fast aggressive evolution resulted in a negative outcome, even with antibiotics treatment and surgical evacuation of the abscess.

24 September 2026 in Life
Verified
Journal Article
Open access
PDF file
BIBogdan Florin Iliescu
Bogdan Florin Iliescu
Loredana Mariana CurecheriuLoredana Mariana Curecheriu
Loredana Mariana Curecheriu
BCBogdan Costachescu
Bogdan Costachescu
CCClaudia Florida Costea
Claudia Florida Costea
DRDaniel Ilie Rotariu
Daniel Ilie Rotariu
Background: Pituitary carcinoma (PC) is a rare and aggressive pituitary neuroendocrine tumor (PitNET) defined by non-contiguous craniospinal or systemic metastatic spread. Evidence guiding treatment is limited to case reports and case series. This systematic review aimed to characterize the clinicopathological features, treatment patterns, and prognostic determinants of PC through pooled individual patient data (IPD) analysis. Methods: A systematic search of PubMed/MEDLINE and Embase (January 1990 to March 2026) was conducted in accordance with PRISMA 2020 guidelines (PROSPERO: CRD420261402665). Individual patient data were extracted for 56 pre-specified variables from the identified literature. Two additional institutional cases were analyzed separately as illustrative clinical examples and are not part of the pooled statistical cohort. Survival was estimated using the Kaplan–Meier method with log-rank tests. Univariate and multivariable Cox proportional hazards regression and binary logistic regression (outcome: long-survivor status, defined as OS > 24 months) were performed on the pooled literature cohort. Results: A total of 111 patients from 93 papers were included (51 males (45.9%); median age at PC diagnosis 54 years (IQR 40–61)), with corticotroph lineage predominating (47.7%). Median OS from PC diagnosis was 19 months (IQR 9.5–46); one-year OS was 67.7% and two-year OS 52.0%. Multimodal treatment was associated with significantly longer OS (median 45 vs. 12 months; log-rank p = 0.004). In multivariable Cox regression (n = 88; C-index 0.725), any objective treatment response (HR 0.245, 95% CI 0.101–0.593, p = 0.002), functional tumor status (HR 2.041, 95% CI 1.017–4.095, p = 0.045), and age at PC diagnosis (HR 1.018/year, p = 0.049) were independently associated with OS. Logistic regression identified multimodal treatment (OR 5.29, p = 0.009), any treatment response (OR 5.47, p = 0.006), and early metastasis (OR 0.18, p = 0.024) as independent predictors of long-survivor status. Ki-67 increased significantly from initial to PC-stage diagnosis (median 7% vs. 12%; Wilcoxon p < 0.001), which is, to our knowledge, the first demonstration of this longitudinal rise in a pooled pituitary carcinoma cohort. Conclusions: PC carries a poor prognosis, with a median OS of 19 months. Multimodal therapy and achievement of objective response are the strongest determinants of prolonged survival. Prospective registries with standardized molecular profiling are needed to advance precision management of this ultra-rare malignancy.

23 April 2026 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
Loredana Mariana CurecheriuLoredana Mariana Curecheriu
Loredana Mariana Curecheriu
ICIvona Costachescu
Ivona Costachescu
Andrei SzilagyiAndrei Szilagyi
Andrei Szilagyi
GRGogu Maria Raluca
Gogu Maria Raluca
BIBogdan Florin Iliescu
Bogdan Florin Iliescu
MTMihaela Dana Turliuc
Mihaela Dana Turliuc
Background: Intracerebral administration of amyloid-β (Aβ) peptides remains a widely used experimental approach for modeling key neurochemical features of Alzheimer's disease (AD), including neuroinflammation, oxidative stress, and synaptic dysfunction. Among these models, Aβ 1−42 and Aβ 1−40 are most frequently employed. However, their effects are often treated as interchangeable despite recognized differences in aggregation behavior and biological activity. Objective: This systematic review aimed to synthesize evidence on how peptide selection between Aβ 1−42 and Aβ 1−40 shapes neurochemical outcomes in intracerebral rat models of AD. Methods: The review was conducted in accordance with PRISMA guidelines and registered in PROSPERO. A structured search identified in vivo rat studies using Aβ 1−42 or Aβ 1−40 . Given methodological heterogeneity, findings were synthesized using a qualitative framework. To address potential structural confounding, stratified analyses were performed according to injection route and aggregation state. Results: Eighty-three studies met inclusion criteria (Aβ 1−42 = 60; Aβ 1−40 = 23). Across neurochemical domains, Aβ 1−42 was more frequently associated with earlier and glial activation, increased pro-inflammatory mediators, oxidative imbalance, and synaptic alterations, often accompanied by behavioral deficits. In contrast, Aβ 1−40 models showed a more variable and generally attenuated neurochemical response with greater dependence on experimental parameters. Structural analyses indicated clustering by injection route, whereas aggregation-state distribution was not statistically skewed between peptides. Conclusions: The available evidence suggests that Aβ 1−42 and Aβ 1−40 should not be assumed interchangeable without explicit methodological consideration. Observed differences appear context-dependent and influenced by experimental design variables. Peptide selection with defined mechanistic objectives may enhance interpretability and translational relevance in preclinical AD research.